Cardiometabolic Podcasts — Companies Discussing Cardiometabolic in Earnings Calls & Investor Presentations

Viking Therapeutics, Inc. Announced Q1 2026 Earnings on April 29, 2026, Reporting "a net loss of $158.3 million or $1.37 per share" artwork

Viking Therapeutics, Inc. Announced Q1 2026 Earnings on April 29, 2026, Reporting "a net loss of $158.3 million or $1.37 per share"

Viking Therapeutics Inc. (VKTX)

Apr 30, 2026 • 20:54 •Ep 113 •The Earnings Debate •▶ Play on Apple